Follow timely coverage of the International Stroke Conference right here on Neurology Advisor.
Just days after it received FDA approval, Marathon's Emflaza is under fire from critics who claim the price of the Duchenne muscular dystrophy drug is exorbitant.
Still feeling aftershocks from its failed Alzheimer's trial, Eli Lilly announced more layoffs while Biogen faces an investigation into its payment programs for its top MS drugs.
Traumatic brain injury continues to make major headlines as a new crop of lawsuits hit the docket ahead of Super Bowl LI. Plus, are we too quick to rush to in-human trials? The authors of an op-ed in Nature think so.
One US town tries to take Big Pharma to court over the opioid crisis while the FDA continues to approve new, abuse-deterrent opioids. Plus, the first patient with refractory mesial temporal lobe epilepsy has undergone laser ablation surgery as part of the SLATE trial.
UCB Pharma looks to expand its epilepsy drug as Biogen cuts a deal to protect Tecfidera, while insiders suggest that pharmacists should play a bigger role in managing the growing Alzheimer's dementia population.
The medical community questions whether mobile stroke units are sustainable, new research further links concussions with Alzheimer's disease, and a new trial examines the effects of fasting on MS.
Happy New Year! Reflect on some of 2016's greatest neurological advances and look forward as institutions like the NIH take on a focused effort to explore new drugs for rare disease, the developing brain, and more.
The FDA has delayed the decision on ocrelizumab after manufacturing issues arise, while it gives the thumbs up to an investigational treatment for complex regional pain syndrome.
The NCAA honored the man and ALS patient behind the viral ALS Ice Bucket Challenge, while the UK approved mitochondrial replacement reproductive assistance and Bristol-Myers Squibb faces a $20 million fine for promoting off-label uses of its antipsychotic Abilify.
Neurology Advisor Articles
- Cannabis: Current Evidence and Research Recommendations
- Addressing Gender Differences in Concussion Diagnosis and Treatment
- Relapsing-Remitting Multiple Sclerosis Halted With Immunosuppression, Stem Cell Transplant
- Maternal Antiepileptic Use and Risk for Major Congenital Malformations in Offspring
- In Stroke, No Clear Benefit for Head Positioning